Publications:

LRRK2 Structure-Based Activation Mechanism and Pathogenesis.

Biomolecules

Zhang, Xiaojuan X; Kortholt, Arjan A

Publication Date: 2023-03-28

Variant appearance in text: LRRK2: G2294R

PubMed Link: 37189360

Variant Present in the following documents:

• Main text
• biomolecules-13-00612.pdf

View BVdb publication page

Is Glial Dysfunction the Key Pathogenesis of LRRK2-Linked Parkinson's Disease?

Biomolecules

Iseki, Tatou T; Imai, Yuzuru Y; Hattori, Nobutaka N

Publication Date: 2023-01-15

Variant appearance in text: LRRK2: G2294R

PubMed Link: 36671564

Variant Present in the following documents:

• Main text
• biomolecules-13-00178.pdf

View BVdb publication page

Mind the Gap: LRRK2 Phenotypes in the Clinic vs. in Patient Cells.

Cells

Goveas, Liesel L; Mutez, Eugénie E; Chartier-Harlin, Marie-Christine MC; Taymans, Jean-Marc JM

Publication Date: 2021-04-22

Variant appearance in text: N/A

PubMed Link: 33922322

Variant Present in the following documents:

View BVdb publication page

A Novel LRRK2 Variant p.G2294R in the WD40 Domain Identified in Familial Parkinson's Disease Affects LRRK2 Protein Levels.

International Journal Of Molecular Sciences

Ogata, Jun J; Hirao, Kentaro K; Nishioka, Kenya K; Hayashida, Arisa A; Li, Yuanzhe Y; Yoshino, Hiroyo H; Shimizu, Soichiro S; Hattori, Nobutaka N; Imai, Yuzuru Y

Publication Date: 2021-04-02

Variant appearance in text: LRRK2: 6880G>A; G2294R

PubMed Link: 33918221

Variant Present in the following documents:

• Main text

View BVdb publication page